Synthetic peptide (Human).
Apoptosis is related to many diseases and development. Caspase-9 plays a central role in cell death induced by a variety of apoptosis activators. Cytochrome c, after released from mitochondria, binds to Apaf-1, which forms an apoptosome that in turn binds to and activate procaspase-9. Activated caspase-9 cleaves and activates the effector caspases (caspase-3, -6 and –7), which are responsible for the proteolytic cleavage of many key proteins in apoptosis. The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were recently identified as important regulators of mitochondrion apoptosis. PHAP appears to facilitate apoptosome-mediated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both Ras- and Myc-mediated cell transformation.
Our Abpromise guarantee covers the use of ab5991 in the following tested applications.
|WB||Use a concentration of 0.5 - 2 µg/ml. Detects a band of approximately 32 kDa.Can be blocked with PHAP1 peptide (ab6240).|
|ICC/IF||Use a concentration of 20 µg/ml.|
|Blocking||Use at an assay dependent concentration. PubMed: 16489023|
|IHC-P||Use a concentration of 2 µg/ml.|
ab5991 at 2µg/ml staining PHAP1 in mouse small intestine tissue by IHC